Detalles de la búsqueda
1.
Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Oncology;
102(4): 318-326, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778345
2.
Factors associated with survival of patients with advanced lung cancer and long travel distances.
J Formos Med Assoc;
123(2): 273-282, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37633771
3.
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib.
Oncologist;
25(8): 702-711, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32386255
4.
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population.
J Immunol;
197(12): 4613-4625, 2016 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27837105
5.
Safety and Efficacy of Intravesical Epinephrine Instillation in Patients with Intractable Lower Urinary Tract Hematuria - A Novel Approach.
Urology;
175: 216-222, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36805415
6.
Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system.
Eur J Cancer;
193: 113310, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37722270
7.
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer.
Cancer Med;
2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140788
8.
Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis.
Front Immunol;
13: 784528, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35222372
9.
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.
Cancer Discov;
12(7): 1676-1689, 2022 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35404393
10.
Lysine Deprivation Induces AKT-AADAT Signaling and Overcomes EGFR-TKIs Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
Cancers (Basel);
13(2)2021 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33450879
11.
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC.
JTO Clin Res Rep;
2(1): 100099, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589970
12.
Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristics.
J Leukoc Biol;
107(2): 323-339, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31749181
13.
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors.
Eur J Cancer;
124: 110-122, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31760310
14.
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.
Front Immunol;
10: 1312, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31231400
15.
Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death.
J Thorac Oncol;
14(6): 1032-1045, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30771522
16.
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.
Blood Adv;
3(7): 1084-1091, 2019 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30944100
17.
Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan.
J Cancer;
9(10): 1813-1820, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29805708
18.
Bone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell Transplantation.
Transplantation;
101(11): 2695-2704, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28319565
19.
Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations.
Sci Rep;
7(1): 7066, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28765579
20.
The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia.
Blood Adv;
1(13): 802-811, 2017 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29296724